Cosmo N.V.
CMHC · SIX · CHF
CHF 51.90
+0.00 0.00%todayNot financial advice.
- Open
- 52.00
- Day range
- 51.10 - 52.20
- 52-week range
- 49.00 - 129.40
- Volume
- 29.65K
- Market cap
- 1.06B
- P/E ratio
- —
- EPS
- -0.43
- Dividend yield
- 3.72%
- Beta
- 1.46
Performance
W
+1.37%
1M
+0.19%
3M
−17.62%
6M
−46.27%
YTD
−51.50%
Y
−22.07%
5Y
−26.59%
All
+153.79%
In the news
Oct 19
Cosmo N.V. Gel Reaches Phase 2 Remission Endpoint in Ulcerative Colitis Trial
Cosmo N.V. reported Phase 2 success for its topical rifamycin gel in ulcerative colitis, clearing a key milestone ahead of Phase 3 regulatory talks.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/SIX-CMHC" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Cosmo N.V. (CMHC) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/SIX-CMHC">CMHC stock price</a> by FreeTheAI Stocks</p>